Intrathecal Bupivacaine Versus Bupivacaine and Clonidine in Paediatrics Age Group:A Comparative Evaluation

NCT01661803 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2012-08-10

No results posted yet for this study

Summary

The investigators can summarize intrathecal clonidine can potentiate bupivacaine thereby bringing about better quality and longer duration of analgesia, better sedation and better postoperative outcomes with minimal side effects.

Conditions

  • Pediatric Spinal Anesthesia

Sponsors & Collaborators

  • ACPM Medical College

    lead OTHER

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2012-01-31
Completion
2012-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01661803 on ClinicalTrials.gov